KLICKMER
LIVE

Serial Number

79311991

Owner

Immudex ApS

Attorney

Miriam D. Trudell

Filing Date

Feb 5, 2021

Add to watchlist:

No watchlists yet
View on USPTO

KLICKMER Trademark

Serial Number: 79311991 • Registration: 6720843

KLICKMER is a trademark filed by Immudex ApS on February 5, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Immudex ApS (8 trademarks)

Bredevej 2A

Entity Type: 99

Trademark Details

Filing Date

February 5, 2021

Registration Date

May 24, 2022

Published for Opposition

February 22, 2022

Goods & Services

Preparations for pharmaceutical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccines, immunotherapeutics and cellular therapies, including cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy and other medical therapies, for analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases, and for use in connection with medical procedures and diagnosis, namely, transplantation, immune monitoring, and vaccines and T-cell monitoring

Chemicals used in diagnostics, industry and science, other than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagents, monoclonal antibodies, reagents, diagnostic agents, control reagents, DNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for analysis for research purposes of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis for research purposes of infectious diseases, autoimmunity and for use in connection with toxicological studies and research in relation to transplantation, immune monitoring, vaccines and T-cell monitoring; chemical reagents other than for medicinal and veterinary purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 12, 2024 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 12, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 14, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 14, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 14, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 14, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 14, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 14, 2023 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 3, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 9, 2022 FICS
FINAL DISPOSITION PROCESSED
Sep 9, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 24, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 24, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
May 24, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 22, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 22, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Feb 20, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 2, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 2, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 2, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 20, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 13, 2022 TROA
REFUSAL PROCESSED BY IB
Oct 4, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 13, 2021 RFCS
REFUSAL PROCESSED BY MPU
Sep 13, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 1, 2021 RFCR
NON-FINAL ACTION WRITTEN
Aug 31, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 30, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 8, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 2, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 27, 2021 REPR